Sree Rayalaseema Hi-Strength Hypo Share Price & Earnings Call Analysis

₹490.20-2.78% today

Market cap: ₹841 Cr
P/E: 8.54
ROE: 10.52%
PEG: -0.76
Price to sales: 1.21
Debt to equity: 0.01
52W high / low: ₹628 / ₹384
Sales growth (5Y): -6.04%
EBITDA margin: 12.50%
Net profit margin: 14.71%
Promoter holding: 62.19%
Sales (last year): ₹698 Cr

All 12 ratios ↓

Incorporated in 2005, Sree Rayalaseema Hi – Strength Hypo Ltd is a producer of producer of Calcium Hypo -chloride, Stable Bleaching Powder, Sulphuric Acid and other chemicals[1]

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

See all potential multibaggers Where does Sree Rayalaseema Hi-Strength Hypo rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

1. Pick 3–15 stocks
2. Choose large, mid or small cap and your sectors
3. Get a portfolio built from the rankings

Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#	Company	Revenue guided	Margin guided	Market cap	P/E
1		40%+	Up 0–2%	₹234 Cr	3.0
2		40%+	Flat	₹3,888 Cr	48.5
3		40%+	Flat	₹3,514 Cr	4.3
4		40%+	Flat	₹180 Cr	11.9
5		40%+	Flat	₹138 Cr	15.1
6		20–40%	Up 2%+	₹1.70L Cr	85.4

Sign up free to see every company in the sector ranking and track Sree Rayalaseema Hi-Strength Hypo.

Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals ranking

Financials of Sree Rayalaseema Hi-Strength Hypo

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Sree Rayalaseema Hi-Strength Hypo

Quarterly Results

Quarter-by-quarter operating performance

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales +	301	435	261	226	215	165	169	170	138	160	180	182	141
Expenses +	274	371	226	199	192	138	142	140	117	143	152	155	121
Operating Profit	26	64	35	26	22	27	27	30	21	18	28	27	20
OPM %	9%	15%	13%	12%	10%	16%	16%	18%	15%	11%	16%	15%	14%
Other Income +	11	20	1	2	4	5	3	9	13	12	6	7	16
Interest	0	1	1	1	1	2	0	0	0	1	0	0	0
Depreciation	5	5	3	3	3	3	1	2	1	1	1	1	1
Profit before tax	32	79	33	25	23	27	28	36	32	28	32	32	35
Tax %	26%	9%	26%	27%	29%	23%	26%	29%	27%	19%	28%	24%	30%
Net Profit +	24	71	24	18	17	21	20	26	24	23	23	24	24
EPS in Rs	13.72	41.45	14.17	10.78	9.69	12.22	11.94	15.12	13.71	13.23	13.64	14.20	14.16

Financials of Sree Rayalaseema Hi-Strength Hypo

Profit & Loss

Annual income statement trend

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales +	295	392	362	366	546	702	689	911	1,267	1,650	866	638	664
Expenses +	262	351	318	317	500	604	587	781	1,119	1,470	755	542	570
Operating Profit	33	41	44	50	46	98	102	130	149	180	111	96	94
OPM %	11%	10%	12%	14%	8%	14%	15%	14%	12%	11%	13%	15%	14%
Other Income +	9	9	2	-2	19	5	4	7	11	34	13	36	41
Interest	16	14	11	8	9	16	10	5	3	5	4	2	2
Depreciation	15	10	10	25	19	45	50	51	19	19	11	6	6
Profit before tax	12	26	26	15	37	42	45	81	137	190	109	124	127
Tax %	36%	25%	27%	-27%	1%	52%	17%	25%	25%	19%	26%	25%
Net Profit +	7	19	19	18	37	20	38	61	103	154	80	93	95
EPS in Rs	5.06	13.16	12.72	11.86	22.45	11.90	22.09	35.30	59.88	89.90	46.85	53.99	55.23
Dividend Payout %	0%	11%	12%	13%	9%	17%	11%	8%	6%	4%	6%	6%

Financials of Sree Rayalaseema Hi-Strength Hypo

Balance Sheet

Capital structure and asset base

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	15	15	15	15	16	17	17	17	17	17	17	17	17
Reserves	135	157	173	222	302	308	294	371	553	734	785	905	993
Borrowings +	88	87	85	55	78	52	57	72	28	16	5	15	13
Other Liabilities +	130	99	84	60	64	93	76	59	189	174	100	121	133
Total Liabilities	367	358	357	352	460	470	445	519	787	941	907	1,059	1,156
Fixed Assets +	200	194	195	182	194	194	161	134	130	105	103	112	111
CWIP	0	5	2	8	0	0	3	0	0	0	0	0	0
Investments	32	23	23	43	105	65	18	50	164	268	253	366	407
Other Assets +	135	136	137	118	161	210	262	334	494	568	551	580	638
Total Assets	367	358	357	352	460	470	445	519	787	941	907	1,059	1,156

Financials of Sree Rayalaseema Hi-Strength Hypo

Cash Flows

Operating, investing and financing cash movement

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	20	36	15	47	5	60	99	71	60	131	132	88
Cash from Investing Activity +	-9	-5	-3	-19	-27	-24	-38	-115	-1	-99	-8	-40
Cash from Financing Activity +	-9	-32	-12	-19	16	-37	-22	10	-52	-20	-22	-8
Net Cash Flow	2	-1	-0	8	-6	-1	40	-35	7	12	103	39
Free Cash Flow	12	14	8	28	-23	15	91	50	46	136	123	85
CFO/OP	73%	104%	49%	106%	2%	72%	108%	82%	62%	117%	145%	124%

Financials of Sree Rayalaseema Hi-Strength Hypo

Ratios

Working capital efficiency and return ratios

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	33	33	54	30	38	46	43	39	38	33	45	59
Inventory Days	67	42	37	55	34	34	36	27	62	39	24	49
Days Payable	97	79	39	66	21	38	24	8	33	22	10	18
Cash Conversion Cycle	3	-4	51	19	51	41	55	57	67	50	59	90
Working Capital Days	-23	-15	1	12	16	32	24	23	47	45	67	79
ROCE %	11%	13%	14%	9%	9%	14%	15%	21%	26%	26%	16%	15%

Momentum score · price trend

28 out of 100 — Cooling

Over the past year its share price has done worse than most of the stocks we track.

Period	Share price change	Better than … of 1,910 stocks
Last 12 months	−8.7%	50%
Last 6 months	−1.3%	52%
Last 3 months	+2.0%	72%

The price is 43.6% below its all-time high of ₹893.8 (11 Oct 2024). Stocks more than 20% below their peak have their score halved, so 55 became 28.

How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Sree Rayalaseema Hi-Strength Hypo: 0.4 × 50 + 0.4 × 52 + 0.2 × 72 = 55, halved to 28 because the price is more than 20% below its all-time high.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 2 Nov 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Others in Chemicals & Petrochemicals this season

J.G.Chemicals (Q2 FY27)
Q2 FY27 Revenue from Operations: ₹3,610 million, up 63.9% YoY (₹2,203 million in Q2 FY26) (Page 23) . Key investor presentation takeaways from J.G.Chemicals Ltd
Lords Chloro (Q2 FY27)
115.40 Crore, up 17.34% YoY from Rs. Key investor presentation takeaways from Lords Chloro Alkali Ltd's Q2 FY27 investor presentation — and how it ranks against
Camlin Fine (Q2 FY27)
Q2 FY27 revenue: Rs 4,915 mn, up 9.15% YoY from Rs 4,503 mn in Q2 FY26 (Page 6, 9) . Key investor presentation takeaways from Camlin Fine Sciences Ltd's Q2 FY27
Gujarat Fluoroch (Q2 FY27)
Consolidated Q2FY27 revenue: ₹1,760 crore, up 45% YoY (Q2FY26: ₹1,210 crore). Key investor presentation takeaways from Gujarat Fluorochemicals Ltd's Q2 FY27 inv

Compare:vs Solar Industries vs Pidilite Industries vs SRF